These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 12453012)

  • 21. Successful treatment of perianal warts in a child with 5% imiquimod cream.
    Gruber PC; Wilkinson J
    J Dermatolog Treat; 2001 Dec; 12(4):215-7. PubMed ID: 12241631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Application of imiquimod and resiquimod in dermatology].
    Xu KJ; Liu YH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):445-7. PubMed ID: 16900654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New perspective in immunotherapy: local imiquimod treatment].
    Kemény L; Nagy N
    Orv Hetil; 2010 May; 151(19):774-83. PubMed ID: 20427260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV-positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia.
    Sanclemente G; Herrera S; Tyring SK; Rady PL; Zuleta JJ; Correa LA; He Q; Wolff JC
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1054-60. PubMed ID: 17714124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mechanisms of imiquimod indirect antiviral activity].
    Hober D; Ajram L; Chehadeh W; Lazrek M; Goffard A; Dewilde A; Wattré P
    Ann Biol Clin (Paris); 2005; 63(2):155-63. PubMed ID: 15771973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of genital warts with an immune-response modifier (imiquimod).
    Beutner KR; Spruance SL; Hougham AJ; Fox TL; Owens ML; Douglas JM
    J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):230-9. PubMed ID: 9486679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imiquimod: a potential role in dermatology?
    Eedy DJ
    Br J Dermatol; 2002 Jul; 147(1):1-6. PubMed ID: 12100177
    [No Abstract]   [Full Text] [Related]  

  • 28. Imiquimod as a dermatological therapy.
    Tran H; Moreno G; Shumack S
    Expert Opin Pharmacother; 2004 Feb; 5(2):427-38. PubMed ID: 14996638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel dermatologic uses of the immune response modifier imiquimod 5% cream.
    Berman B; Poochareon VN; Villa AM
    Skin Therapy Lett; 2002 Nov; 7(9):1-6. PubMed ID: 12548325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imiquimod stimulates innate and cell mediated immunity which controls virus infections and tumors.
    Miller R
    Int J Dermatol; 2002 May; 41 Suppl 1():3-6. PubMed ID: 12087815
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of anogenital warts with imiquimod 5% cream followed by surgical excision of residual lesions.
    Carrasco D; vander Straten M; Tyring SK
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S212-6. PubMed ID: 12271280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imiquimod in clinical practice.
    Edwards L
    J Am Acad Dermatol; 2000 Jul; 43(1 Pt 2):S12-7. PubMed ID: 10861102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical Imiquimod is an Effective and Safe Drug for Molluscum Contagiosum in Children.
    Badavanis G; Pasmatzi E; Monastirli A; Georgiou S; Tsambaos D
    Acta Dermatovenerol Croat; 2017 Jul; 25(2):164-166. PubMed ID: 28871935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential.
    Stanley MA
    Clin Exp Dermatol; 2002 Oct; 27(7):571-7. PubMed ID: 12464152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical imiquimod treatment of human papillomavirus in a patient with human immunodeficiency virus.
    Gilbert J; Drehs MM; Weinberg JM
    Acta Derm Venereol; 2001; 81(4):301-2. PubMed ID: 11720183
    [No Abstract]   [Full Text] [Related]  

  • 36. Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study.
    Saiag P; Bauhofer A; Bouscarat F; Aquilina C; Ortonne JP; Dupin N; Mougin C
    Br J Dermatol; 2009 Oct; 161(4):904-9. PubMed ID: 19466962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy and safety of 5% imiquimod cream in external genital warts: a 6 month follow-up evaluation].
    Vexiau D; Decuypère L; Moyse D; Aractingi S
    Ann Dermatol Venereol; 2005 Nov; 132(11 Pt 1):845-51. PubMed ID: 16327713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imiquimod is a strong inhibitor of tumor cell-induced angiogenesis.
    Majewski S; Marczak M; Mlynarczyk B; Benninghoff B; Jablonska S
    Int J Dermatol; 2005 Jan; 44(1):14-9. PubMed ID: 15663652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imiquimod: mode of action and therapeutic potential.
    Chosidow O; Dummer R
    Acta Derm Venereol Suppl (Stockh); 2003 Sep; (214):8-11. PubMed ID: 14606276
    [No Abstract]   [Full Text] [Related]  

  • 40. Beyond a decade of 5% imiquimod topical therapy.
    A Gaspari A; Tyring SK; Rosen T
    J Drugs Dermatol; 2009 May; 8(5):467-74. PubMed ID: 19537370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.